Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | ACHE | P22303 | 2/20 | 0.40 |
| ▸ | CD44 | P16070 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA7 | P43166 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | MYC | P01106 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1395553 | 0.84 | CA1 (0.33) | CYP2A6CYP1A2TSHRACHECD44 | |
| SCHEMBL6310961 | 0.82 | ACHE (0.38) | CYP2A6CYP1A2ACHE | |
| SCHEMBL3223109 | 0.75 | CYP1A2 (0.40) | CYP2A6CYP1A2TSHRACHECD44 | |
| SCHEMBL4021982 | 0.75 | ACHE (0.57) | CYP2A6CYP1A2TSHRACHECD44 | |
| SCHEMBL7624698 | 0.74 | CYP2A6 (0.43) | CYP2A6CYP1A2TSHRACHECD44 | |
| SCHEMBL5153405 | 0.74 | TSHR (0.43) | CYP2A6CYP1A2TSHRACHEALDH1A1 | |
| SCHEMBL820110 | 0.72 | ACHE (0.33) | CYP2A6CYP1A2TSHRACHECD44 | |
| SCHEMBL28898710 | 0.69 | CD44 (0.33) | CYP2A6CYP1A2TSHRACHECD44 | |
| SCHEMBL3094328 | 0.69 | CYP2A6 (0.43) | CYP2A6CYP1A2TSHRACHECD44 | |
| SCHEMBL4161420 | 0.67 | CA1 (0.48) | CYP2A6CYP1A2TSHRACHECD44 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3749674-A1 | MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-12-16 | — | — | EP | claimed |
| US-20200369697-A1 | MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2020-11-26 | — | — | US | claimed |
| WO-2019157376-A1 | MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2019-08-15 | — | — | WO | claimed |
| JP-4467181-B2 | — | — | 2010-05-26 | — | — | JP | claimed |
| EP-1125979-B1 | Polymer blends | INEOS EUROPE LTD (GB) | 2006-11-29 | — | — | EP | claimed |
| US-6894127-B2 | Polymerization process | BP CHEMICALS LIMITED (GB) | 2005-05-17 | — | — | US | claimed |
| US-6828398-B2 | Transition metal complex containing pyrimidine or pyrazine compound used as polymerization catalysts for alpha-olefins | BP CHEMICALS LIMITED (GB) | 2004-12-07 | — | — | US | claimed |
| EP-1062250-B1 | POLYMERISATION CATALYSTS | BP CHEM INT LTD (GB) | 2004-07-14 | — | — | EP | claimed |
| US-20040063878-A1 | Polymerisation process | BP CHEMICALS LIMITED (GB) | 2004-04-01 | — | — | US | claimed |
| US-6608140-B2 | Polymer blends | BP CHEMICALS LIMITED (GB) | 2003-08-19 | — | — | US | claimed |
| WO-2001012684-A1 | POLYMERISATION PROCESS | BP CHEMICALS LIMITED (GB) | 2001-02-22 | — | — | WO | claimed |
| EP-1062250-A1 | POLYMERISATION CATALYSTS | BP Chemicals Limited (GB) | 2000-12-27 | — | — | EP | claimed |
| WO-2000069869-A1 | POLYMERISATION CATALYSTS | BP CHEMICALS LIMITED (GB) | 2000-11-23 | — | — | WO | claimed |
| WO-2000058320-A1 | PYRIDINE.IMINE POLYMERISATION CATALYSTS | BP CHEMICALS LIMITED (GB) | 2000-10-05 | — | — | WO | claimed |
| WO-2000047586-A1 | METAL COMPLEXES USEFUL AS POLYMERIZATION CATALYST | BP CHEMICALS LIMITED (GB) | 2000-08-17 | — | — | WO | claimed |
| EP-1015501-A1 | POLYMERISATION CATALYSTS | BP Chemicals Limited (GB) | 2000-07-05 | — | — | EP | claimed |
| WO-2000008034-A1 | PREPARATION OF POLYMERISATION CATALYSTS | BP CHEMICALS LIMITED (GB) | 2000-02-17 | — | — | WO | claimed |
| EP-0953571-A1 | Catalysts for olefin polymerisation | BP Chemicals Limited (GB) | 1999-11-03 | — | — | EP | claimed |
| WO-1999046303-A1 | POLYMERISATION CATALYSTS | BP CHEMICALS LIMITED (GB) | 1999-09-16 | — | — | WO | claimed |
| WO-1999012981-A1 | POLYMERISATION CATALYSTS | BP CHEMICALS LIMITED (GB) | 1999-03-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200369697-A1 | MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS | MSRB3, MMAB, CYB5R3 | CYP2A6 311/4885CYP1A2 137/4885TSHR 2953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.